A multinational team analysing four TrialNet trials reports that children under eight years progressing rapidly to clinical type 1 diabetes show a paradoxically higher insulin

An AdventHealth team reports that plasma-derived extracellular vesicle (EV) proteomics can distinguish partial clinical remission (PCR) in new-onset type 1 diabetes, pointing to a circulating

A team from Boston and Tampa proposes ‘Time to Minimum Residual C-Peptide’ (TMRCP), a longitudinal endpoint that captures the trajectory of β-cell secretory loss, as

This study was presented as part of the session “Diabetes and Heart Talk” on June 23rd, 2025, during the 85th ADA Scientific Sessions held in

This study was presented on June 23rd, 2025, during the 85th ADA Scientific Sessions held in Chicago, IL. A groundbreaking obesity treatment combining two medications

This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity” on June 22nd, 2025, at

This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at the 85th ADA Scientific Sessions

This paper was presented as a part of the session” Rising Risks, Real Solutions—Tackling Childhood Type 2 Diabetes and Obesity” on June 22nd, 2025, at

This paper was presented as a part of the session” Late Breaking Poster/ Trials Sessions “on June 22nd, 2025, at the 85th ADA Scientific Sessions

This paper was presented as a part of the session “Dropping Cost and Complications—CVD Risk and DM—SGLT2s and GLPs for CVD” on June 22nd, 2025,